California’s Division of Workers’ Compensation (DWC) issued an update to the Physician and Non-Physician Practitioner portion of the Official Medical Fee Schedule (OMFS) for workers’ compensation, effective for all dates of service on or after July 1, 2024.
The update adds 130 new procedure codes.
The update conforms the OMFS to relevant 2024 Medicare payment system changes, as California Labor Code Section 5307.1 requires. The DWC announced the update in a recent Newsline, and posted the order adopting the update on the DWC website.
daisyBill clients do not need to take any action; we added the new HCPCS to our billing software, which are effective for all dates of service on or after July 1.
Non-daisyBill providers are advised to adjust their systems for dates of services starting July 1.
Read on for details!
The update aligns the OMFS to relevant 2024 changes in the Medicare payment system, as required by California Labor Code Section 5307.1.
Below are the 130 new Healthcare Common Procedure Coding System (HCPCS) codes adopted by the DWC (and CMS) for Q3 2024.
Note that when Medicare fails to assign an HCPCS code a Relative Value Unit (RVU), the reimbursement is calculated “By Report” (BR). California Code of Regulations Section 9789.12.4 provides guidelines for appropriate reimbursement amounts for BR codes.
HCPCS |
Modifier |
Description |
Reimbursement Calculation |
0640T |
TC |
Ncntc ifr spctrsc o/t pad 1 |
By Report |
0640T |
26 |
Ncntc ifr spctrsc o/t pad 1 |
By Report |
0859T |
26 |
Ncntc ifr spctrsc o/t pad ea |
By Report |
0859T |
TC |
Ncntc ifr spctrsc o/t pad ea |
By Report |
0867T |
Tpla b9 prst8 hyprplsa>=50ml |
By Report |
|
0868T |
26 |
Hi-res gastric ep mapping |
By Report |
0868T |
TC |
Hi-res gastric ep mapping |
By Report |
0868T |
Hi-res gastric ep mapping |
By Report |
|
0869T |
Njx b1 sub mtrl hw fixj aug |
By Report |
|
0870T |
Imp subq prtl ascts pmp sys |
By Report |
|
0871T |
Rplcmt subq prtl ascites pmp |
By Report |
|
0872T |
Rplcmt ndwllg bldr&prtl cath |
By Report |
|
0873T |
Revj subq prtl asct pmp sys |
By Report |
|
0874T |
Rmvl pertl ascites pmp sys |
By Report |
|
0875T |
Prgrm subq prtl asct pmp sys |
By Report |
|
0876T |
TC |
Duplex scan hemo fstl lmtd |
By Report |
0876T |
26 |
Duplex scan hemo fstl lmtd |
By Report |
0876T |
Duplex scan hemo fstl lmtd |
By Report |
|
0877T |
Augmnt alys ch ct ild w/o ct |
By Report |
|
0878T |
Augmnt alys ch ct ild w/ct |
By Report |
|
0879T |
Augmnt alys ch ct ild prep |
By Report |
|
0880T |
Augmnt alys ch ct ild i&r |
By Report |
|
0881T |
Cryotherapy oral cavity |
By Report |
|
0882T |
Intraop ther estim pn ue 1st |
By Report |
|
0883T |
Intraop ther estim pn ue ea |
By Report |
|
0884T |
Esphgsc flx 1st tndsc dilat |
By Report |
|
0885T |
Colsc flx 1st tndsc dilat |
By Report |
|
0886T |
Sgmdsc flx 1st tndsc dilat |
By Report |
|
0887T |
End-tidal ctrl inhaled anes |
By Report |
|
0888T |
Histotripsy mal renal tissue |
By Report |
|
0889T |
Prsnlz trgt dvl arhfcmrigtbs |
By Report |
|
0890T |
Arhfcmrigtbs 1st tx day |
By Report |
|
0891T |
Arhfcmrigtbs sbsq tx day |
By Report |
|
0892T |
Arhfcmrigtbs sbsq per tx day |
By Report |
|
0893T |
26 |
N-invas assmt bld oxygnation |
By Report |
0893T |
TC |
N-invas assmt bld oxygnation |
By Report |
0893T |
N-invas assmt bld oxygnation |
By Report |
|
0894T |
Cannulation liver allograft |
By Report |
|
0895T |
Connj lvr algrft prfu dev 1 |
By Report |
|
0896T |
Connj lvr algrft prfu dev ea |
By Report |
|
0897T |
TC |
N-invas augmnt arrhyt alys |
By Report |
0897T |
N-invas augmnt arrhyt alys |
By Report |
|
0897T |
26 |
N-invas augmnt arrhyt alys |
By Report |
0898T |
TC |
N-invas prst8 cancer est map |
By Report |
0898T |
26 |
N-invas prst8 cancer est map |
By Report |
0898T |
N-invas prst8 cancer est map |
By Report |
|
0899T |
26 |
N-invas deter aqmbf aug cmr |
By Report |
0899T |
N-invas deter aqmbf aug cmr |
By Report |
|
0899T |
TC |
N-invas deter aqmbf aug cmr |
By Report |
0900T |
26 |
N-invas est aqmbf asstv cmr |
By Report |
0900T |
TC |
N-invas est aqmbf asstv cmr |
By Report |
0900T |
N-invas est aqmbf asstv cmr |
By Report |
|
90637 |
Vacc qirv mrna 30mcg/.5ml im |
By Report |
|
90638 |
Vacc qirv mrna 60mcg/.5ml im |
By Report |
|
A2026 |
Restrata minimatrix, 5 mg |
By Report |
|
A4271 |
Home lancing/test cartridges |
Section 9789.60 establishes payment conditions |
|
A4438 |
Adhesive clip ext ens contr |
Section 9789.60 establishes payment conditions |
|
A4564 |
Pessary, disposable any type |
By Report |
|
A4593 |
Neuromod sti sys adj rehab |
By Report |
|
A4594 |
Neuromod adj rehab mouthpie |
By Report |
|
A9293 |
Fertility cycl tracking soft |
By Report |
|
A9506 |
Tc-99m graphite crucible |
By Report |
|
G0519 |
New pt-cg dyad dem low cmplx |
By Report |
|
G0520 |
New pt-cg dyad dem mod cmplx |
By Report |
|
G0521 |
New pt-cg dyad dem hig cmplx |
By Report |
|
G0522 |
Mgt nw pt dementia low cmplx |
By Report |
|
G0523 |
Mgt nw pt dem mod-high cmplx |
By Report |
|
G0524 |
Est pt-cg dyad dem low cmplx |
By Report |
|
G0525 |
Est pt-cg dyad dem mod cmplx |
By Report |
|
G0526 |
Est pt-cg dyad dem hig cmplx |
By Report |
|
G0527 |
Mgt est pt dmentia low cmplx |
By Report |
|
G0528 |
Mgt est pt dem mod-hi cmplx |
By Report |
|
G0529 |
In home respite care, 4 hr u |
By Report |
|
G0530 |
Adult daycare center, 8 hr u |
By Report |
|
G0531 |
Fclty-based respite, 24 hr u |
By Report |
|
G9037 |
Intrpro req fr rec phys/qhcp |
RVU+GPCI+CF |
|
G9038 |
Co-management services |
RVU+GPCI+CF |
|
H0051 |
Traditional healing service |
By Report |
|
J0211 |
Inj, nithiodote, 3mg / 125mg |
By Report |
|
J0687 |
Inj cefazolin (wg crit care) |
By Report |
|
J0872 |
Daptomycin (xellia) unrefrig |
By Report |
|
J0911 |
Inst tauro 1.35mg/hep 100u |
By Report |
|
J1597 |
Inj glycopyrrolate, glyrx-pf |
By Report |
|
J1598 |
Inj glycopyrrolate fres kabi |
By Report |
|
J1748 |
Inj, zymfentra, 10 mg |
By Report |
|
J2183 |
Inj meropenem (wg crit care) |
By Report |
|
J2246 |
Inj, micafungin (baxter) |
By Report |
|
J2267 |
Inj, mirikizumab-mrkz, 1 mg |
By Report |
|
J2373 |
Inj, immphentiv, 20 mcg |
By Report |
|
J2468 |
Inj, palonosetron (avyxa) |
By Report |
|
J2470 |
Inj pantoprazole sodium 40mg |
By Report |
|
J2471 |
Inj pantoprazole(hikma) 40mg |
By Report |
|
J3247 |
Inj secukinumab intrav 1mg |
By Report |
|
J3263 |
Inj, toripalimab-tpzi, 1 mg |
By Report |
|
J3393 |
Inj, betibeglogene autotemce |
By Report |
|
J3394 |
Inj, lovotibeglogene autotem |
By Report |
|
J7171 |
Inj, adzynma, 10 iu |
By Report |
|
J7355 |
Inj travoprost intra impl |
By Report |
|
J8611 |
Oral methotrexate (jylamvo) |
By Report |
|
J8612 |
Oral methotrexate (xatmep) |
By Report |
|
J9361 |
Inj, efbemalenograstim alfa- |
By Report |
|
M0224 |
Pemivibart infusion |
By Report |
|
Q0224 |
Inj, pemivibart, 4500 mg |
By Report |
|
Q4311 |
Acesso, per sq cm |
By Report |
|
Q4312 |
Acesso ac, per sq cm |
By Report |
|
Q4313 |
Dermabind fm, per sq cm |
By Report |
|
Q4314 |
Reeva, per sq cm |
By Report |
|
Q4315 |
Regenelink amniotic mem allo |
By Report |
|
Q4316 |
Amchoplast, per sq cm |
By Report |
|
Q4317 |
Vitograft, per sq cm |
By Report |
|
Q4318 |
E-graft, per sq cm |
By Report |
|
Q4319 |
Sanograft, per sq cm |
By Report |
|
Q4320 |
Pellograft, per sq cm |
By Report |
|
Q4321 |
Renograft, per sq cm |
By Report |
|
Q4322 |
Caregraft, per sq cm |
By Report |
|
Q4323 |
Alloply, per sq cm |
By Report |
|
Q4324 |
Amniotx, per sq cm |
By Report |
|
Q4325 |
Acapatch, per sq cm |
By Report |
|
Q4326 |
Woundplus, per sq cm |
By Report |
|
Q4327 |
Duoamnion, per sq cm |
By Report |
|
Q4328 |
Most, per sq cm |
By Report |
|
Q4329 |
Singlay, per sq cm |
By Report |
|
Q4330 |
Total, per sq cm |
By Report |
|
Q4331 |
Axolotl graft, per sq cm |
By Report |
|
Q4332 |
Axolotl dualgraft, per sq cm |
By Report |
|
Q4333 |
Ardeograft, per sq cm |
By Report |
|
Q5137 |
Inj, wezlana, sub cu, 1 mg |
By Report |
|
Q5138 |
Inj, wezlana, iv, 1 mg |
By Report |
|
S4988 |
Penile contractur devic manu |
By Report |
|
S9002 |
Intra-vag motion sens biofk |
By Report |
Again, bills submitted via daisyBill will automatically reflect the most current, accurate reimbursement rates. If you have any questions regarding this fee schedule update, use the chat function at the bottom right of this screen or email our experts at info@daisybill.com.
DaisyBill provides content as an insightful service to its readers and clients. It does not offer legal advice and cannot guarantee the accuracy or suitability of its content for a particular purpose.